Latest News and Press Releases
Want to stay updated on the latest news?
-
REHOVOT, Israel, July 18, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it...
-
REHOVOT, Israel and CUIABÁ/MT, Brazil, July 17, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science...
-
REHOVOT, Israel, July 10, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets, announced today that...
-
REHOVOT, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets, announced today its...
-
LUDWIGSHAFEN, Germany and REHOVOT, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- BASF, one of the world’s leading chemical companies, and Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology...
-
REHOVOT, Israel, May 14, 2018 (GLOBE NEWSWIRE) -- Biomica, a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), an emerging biopharmaceutical company developing innovative microbiome-based...
-
REHOVOT, Israel, May 10, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it...
-
Evogene and Marrone Bio Innovations Announce Phase Advancement in their Insect Control Collaboration
REHOVOT, Israel and DAVIS, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets, and...
-
REHOVOT, Israel, May 01, 2018 (GLOBE NEWSWIRE) -- Biomica, a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), an emerging biopharmaceutical company developing innovative microbiome-based...
-
REHOVOT, Israel, April 01, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets through the use of a...